Eden Spine announced today that Stephan Rietiker has stepped down from the Board of Directors due to significant and competing workload and responsibilities. He expressed “his continued support for Eden Spine as it enters its next growth stage of growth.”
“Mr. Rietiker has been a company director since 2008, providing insightful strategic guidance during the 2008/2009 global financial meltdown” says Guillaume Viallaneix, CEO, “helping the company to survive and strive during this challenging period. We all wish him the best in his future endeavors.”
Eden Spine’s strategy is to create a US based scalable global spine franchise built around an innovative R&D pipeline and a global sales and distribution network. To achieve this, the company has developed a first-in-class portfolio of motion preservation technologies and licensed or developed a line of fusion technologies. With these product lines, Eden is positioned today in all core segments of the current and emerging spine markets, in the US and internationally.
